◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
COSMOS Pharmaceutical Corporation — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2025May 31, 2025FY 2024May 31, 2024FY 2023May 31, 2023FY 2022May 31, 2022FY 2021May 31, 2021
+Revenue 1011.4B 965.0B 827.7B 755.4B 726.4B
Revenue Growth % 4.8% 16.6% 9.6% 4.0% --
+Operating Income 40.4B 31.5B 30.1B 29.8B 33.1B
Operating Margin % 4.0% 3.3% 3.6% 3.9% 4.6%
Non Operating Income 3.7B 3.6B 3.7B 3.7B 3.4B
Non Operating Expenses 988.0M 839.0M 719.0M 629.0M 736.0M
Ordinary Income 43.2B 34.3B 33.1B 32.9B 35.8B
Income Before Taxes 42.4B 33.7B 32.8B 33.0B 38.6B
Income Taxes 11.4B 9.3B 9.0B 9.9B 11.4B
+Net Income 31.0B 24.5B 23.8B 23.2B 27.2B
Net Margin % 3.1% 2.5% 2.9% 3.1% 3.7%
Eps 390.86 617.22 600.96 584.76 685.80
Depreciation Amortization 22.2B 19.9B 17.4B 15.1B 13.8B
Line ItemFY 2025May 31, 2025FY 2024May 31, 2024FY 2023May 31, 2023FY 2022May 31, 2022FY 2021May 31, 2021
Cash And Deposits 57.0B 52.3B 45.9B 37.4B 55.1B
Current Assets 165.6B 154.3B 137.1B 115.5B 125.1B
Property Plant Equipment 331.1B 295.8B 259.5B 225.3B 195.1B
Noncurrent Assets 359.1B 322.2B 283.9B 247.6B 216.2B
Total Assets 524.8B 476.5B 421.0B 363.1B 341.3B
Current Liabilities 220.7B 213.2B 192.1B 162.1B 159.5B
Total Liabilities 267.3B 245.1B 209.9B 172.5B 170.7B
Retained Earnings 248.3B 222.3B 202.5B 182.0B 162.1B
Total Equity 257.5B 231.4B 211.1B 190.5B 170.6B
Equity Ratio 0.49 0.49 0.50 0.53 0.50
Book Value Per Share 3,248 5,840 5,330 4,811 4,308
Num Employees 5,709 5,512 5,290 5,101 4,872
Roe 0.13 0.11 0.12 0.13 0.17
Line ItemFY 2025May 31, 2025FY 2024May 31, 2024FY 2023May 31, 2023FY 2022May 31, 2022FY 2021May 31, 2021
Operating Cash Flow 52.5B 55.2B 54.4B 32.2B 27.9B
Investing Cash Flow -55.4B -57.3B -49.1B -43.7B -19.4B
Financing Cash Flow 7.7B 8.5B 3.2B -6.2B -5.5B
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...